Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -328,937 | -255,859 | -192,410 | -140,241 | -72,273 |
| Depreciation Amortization | 1,203 | -5,169 | -2,903 | -796 | 147 |
| Accounts payable and accrued liabilities | -2,509 | 1,358 | 4,813 | 2,359 | 2,751 |
| Other Working Capital | 8,011 | 11,596 | 11,442 | 751 | 176 |
| Other Operating Activity | 57,788 | 40,283 | 25,434 | 19,289 | 10,436 |
| Operating Cash Flow | $-264,444 | $-207,791 | $-153,624 | $-118,638 | $-58,763 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,554 | -573 | -2,796 | -6,863 | -1,719 |
| Purchase Of Investment | -687,171 | -255,603 | -348,803 | -177,855 | N/A |
| Sale Of Investment | 289,199 | 294,452 | 253,775 | 60,000 | N/A |
| Investing Cash Flow | $-399,526 | $38,276 | $-97,824 | $-124,718 | $-1,719 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 272,391 | N/A | N/A | N/A | N/A |
| Debt Repayment | -54,635 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 711,995 | 214,451 | 163,536 | 163,558 | 38,061 |
| Other Financing Activity | -51,518 | 0 | 0 | 0 | -85 |
| Financing Cash Flow | $878,233 | $214,451 | $163,536 | $163,558 | $37,976 |
| Beginning Cash Position | 98,165 | 53,229 | 141,141 | 220,939 | 243,445 |
| End Cash Position | 312,428 | 98,165 | 53,229 | 141,141 | 220,939 |
| Net Cash Flow | $214,263 | $44,936 | $-87,912 | $-79,798 | $-22,506 |
| Free Cash Flow | |||||
| Operating Cash Flow | -264,444 | -207,791 | -153,624 | -118,638 | -58,763 |
| Capital Expenditure | -1,554 | -573 | -2,796 | -6,863 | -1,719 |
| Free Cash Flow | -265,998 | -208,364 | -156,420 | -125,501 | -60,482 |